
|Articles|March 11, 2020
Supplements and Featured Publications
- Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies
Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies
Advertisement
This AJMC® Clinical Brief explores the latest evidence-based guidelines on the management of chronic obstructive pulmonary disease (COPD), recent research with real-world utilization data, and the implications of prescription and utilization patterns on COPD healthcare resource utilization and total cost of care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
2
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
Colorblind Devices, Longer-Wavelength Lasers Offer Safer Options for Darker Skin Tones: Ariella Kauvar, MD
5